key
public
health
question
whether
syndrom
surveil
data
provid
earli
warn
infecti
outbreak
one
caus
skeptic
biolog
correl
administr
clinic
data
use
system
rigor
assess
studi
measur
valu
respiratori
data
current
use
syndrom
surveil
system
detect
respiratori
infect
compar
criterion
standard
viral
test
within
pediatr
popul
conduct
longitudin
studi
prospect
valid
emerg
depart
ed
tertiari
care
children
hospit
children
age
year
younger
present
respiratori
syndrom
test
respiratori
syncyti
viru
rsv
influenza
viru
parainfluenza
viru
adenoviru
enteroviru
januari
june
includ
assess
predict
abil
viral
test
fit
gener
linear
model
respiratori
syndrom
count
result
patient
visit
respiratori
syndrom
patient
test
virus
interest
rsv
significantli
relat
respiratori
syndrom
count
adjust
rate
ratio
rr
confid
interv
ci
multivari
model
includ
virus
test
influenza
viru
also
signific
predictor
respiratori
syndrom
count
rr
ci
model
account
observ
variabl
respiratori
syndrom
count
conclus
respiratori
syndrom
surveil
data
strongli
correl
virolog
test
result
pediatr
popul
provid
evid
biolog
valid
surveil
system
realtim
outbreak
detect
system
reli
syndrom
data
may
import
adjunct
current
set
public
health
system
detect
surveil
respiratori
infect
recent
year
syndrom
surveil
shown
promis
identifi
natur
occur
epidem
nonetheless
uncertainti
persist
meaning
methodolog
proport
true
biolog
event
detect
import
sourc
data
mani
syndrom
surveil
system
consist
inform
routin
collect
health
care
personnel
emerg
depart
ed
officebas
visit
type
data
lend
well
use
surveil
acquisit
requir
minim
addit
resourc
frequent
record
electron
enabl
autom
transmiss
rapid
avail
studi
valid
inform
collect
current
surveil
system
primarili
use
clinic
public
health
data
valid
even
though
sourc
shown
provid
accept
standard
addit
greatest
util
surveil
system
would
abil
detect
monitor
infecti
outbreak
capabl
specif
requir
examin
date
studi
assess
abil
syndrom
surveil
system
detect
monitor
infecti
diseas
activ
measur
virolog
diseas
within
survey
popul
measur
valu
current
syndrom
surveil
system
monitor
infecti
respiratori
diseas
compar
surveil
data
respiratori
ill
deriv
ed
popul
result
viral
test
popul
conduct
longitudin
studi
ed
urban
tertiari
care
children
hospit
studi
conduct
part
first
retrospect
data
use
determin
whether
variat
frequenc
posit
viral
cultur
perform
routin
clinic
care
correl
variat
frequenc
case
meet
syndrom
surveil
criteria
respiratori
ill
children
age
year
younger
present
ed
period
januari
juli
present
complaint
relat
respiratori
ill
viral
test
perform
part
routin
clinic
care
includ
analysi
second
part
prospect
valid
studi
perform
valid
use
clinic
collect
viral
cultur
retrospect
analysi
chose
perform
valid
viral
test
collect
routin
care
systemat
select
popul
known
infecti
respiratori
ill
subject
prospect
studi
consist
patient
present
ed
respiratori
ill
decemb
june
met
specif
definit
infecti
respiratori
ill
nasopharyng
aspir
collect
patient
test
respiratori
virus
compar
result
test
histor
time
seri
abl
measur
whether
histor
time
seri
repres
sampl
viral
distribut
among
children
infecti
respiratori
ill
protocol
approv
hospit
institut
review
board
patient
prospect
enrol
obtain
written
inform
consent
parent
assent
child
age
appropri
patient
visit
respiratori
syndrom
identifi
base
present
complaint
routin
elicit
patient
parent
present
ed
record
triag
nurs
freetext
descript
subsequ
numer
encod
use
constrain
list
possibl
code
seventeen
describ
respiratori
problem
use
defin
group
patient
respiratori
ill
use
previous
valid
classif
viral
test
respiratori
syncyti
viru
rsv
influenza
b
virus
parainfluenza
viru
type
adenoviru
enteroviru
perform
hospit
studi
period
identifi
test
order
physician
routin
clinic
care
patient
treat
ed
includ
test
order
hour
ed
visit
hour
ed
visit
captur
test
perform
patient
clinic
visit
referr
ed
patient
admit
hospit
ed
respiratori
ill
test
admiss
result
influenza
b
virus
group
result
parainfluenza
viru
type
test
posit
viru
virus
identifi
includ
analysi
valid
group
screen
patient
age
year
younger
present
ed
respiratori
problem
difficulti
breath
cough
wheez
short
breath
patient
present
fever
also
screen
frequent
complaint
report
parent
young
children
respiratori
ill
patient
screen
determin
whether
met
definit
infecti
respiratori
ill
recruit
studi
defin
infecti
respiratori
ill
presenc
least
follow
symptom
fever
cough
sneez
sore
throat
runni
nose
congest
criterion
chosen
sought
determin
viral
distribut
among
patient
respiratori
infect
alreadi
known
topic
syndrom
surveil
system
potenti
provid
earli
warn
infecti
outbreak
identifi
unusu
pattern
rapidli
avail
data
emerg
depart
chief
complaint
diagnos
author
sought
determin
whether
chief
complaint
data
suggest
respiratori
syndrom
correl
virolog
test
result
pediatr
patient
popul
studi
add
knowledg
demonstr
variat
frequenc
respiratoryrel
chief
complaint
correl
variat
posit
viral
test
studi
add
biolog
valid
use
rapidli
avail
chief
complaint
data
surveil
detect
purpos
studi
affect
practic
individu
patient
may
hasten
develop
accur
method
earli
detect
infecti
epidem
want
examin
abil
surveil
system
track
infecti
respiratori
ill
total
patient
screen
met
enrol
criteria
particip
studi
major
patient
meet
criteria
fever
without
respiratori
symptom
patient
recruit
period
decemb
june
comparison
patient
routin
collect
specimen
time
larg
number
ed
patient
treat
respiratori
ill
winter
small
overlap
patient
compos
valid
group
test
part
routin
clinic
care
analysi
perform
patient
includ
exclud
studi
popul
nasopharyng
aspir
obtain
patient
valid
group
test
rsv
influenza
viru
parainfluenza
viru
adenoviru
small
number
specimen
test
studi
virus
insuffici
volum
brief
shortag
cell
viral
cultur
decemb
rare
rsv
test
read
indetermin
consid
neg
test
result
analysi
routin
clinic
test
patient
includ
direct
immunofluoresc
antibodi
stain
viral
cultur
direct
immunofluoresc
antibodi
assay
use
pool
antibodi
influenza
viru
parainfluenza
viru
rsv
adenoviru
simulfluor
respiratori
screen
light
diagnost
chemicon
intern
temecula
ca
singl
virusspecif
antibodi
imagen
influenza
viru
b
dakocytom
carpinteria
ca
bartel
rsv
dfa
kit
triniti
biotech
carlsbad
ca
virastat
parainfluenza
test
zymetx
inc
oklahoma
citi
ok
adenoviru
antibodi
fitc
reagent
light
diagnost
chemicon
intern
viral
cultur
perform
use
rmk
hel
cell
cultur
cytopath
effect
hemagglutin
stain
immunofluoresc
antibodi
identif
influenza
parainfluenza
viru
rsv
adenoviru
enteroviru
identifi
viral
passag
characterist
cytopath
effect
sampl
valid
set
test
cultur
rmk
cell
influenza
viru
adenoviru
parainfluenza
viru
direct
immunofluoresc
antibodi
rsv
increas
sensit
influenza
viru
specimen
also
assay
revers
transcriptas
polymeras
chain
reaction
ribonucl
acid
purifi
use
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
amplifi
access
rtpcr
system
promega
madison
wi
influenza
b
virus
detect
use
previous
publish
primer
detail
data
analysi
avail
onlin
appendix
appendix
avail
http
wwwannemergmedcom
three
hundr
sixtyon
specimen
collect
period
prospect
recruit
total
test
posit
one
virus
test
posit
rate
individu
virus
rsv
influenza
viru
parainfluenza
viru
adenoviru
period
routin
viral
test
collect
patient
present
ed
posit
posit
rsv
posit
influenza
viru
posit
parainfluenza
viru
posit
adenoviru
subject
recruit
prospect
subsequ
also
test
routin
clinic
care
strong
correl
found
test
group
pearson
correl
coeffici
figur
linear
regress
model
also
reveal
power
associ
similar
result
found
exclud
patient
group
pearson
correl
coeffici
linear
regress
model
associ
strongli
suggest
result
viral
test
obtain
routin
clinic
care
appropri
represent
viral
activ
among
children
treat
ed
infecti
respiratori
ill
support
use
histor
test
result
analysi
use
result
routin
viral
test
studi
period
measur
relationship
preval
winter
respiratori
virus
respiratori
howev
virus
includ
covari
influenza
viru
becam
signific
predictor
adjust
rr
ci
stepwis
remov
variabl
reveal
effect
influenza
viru
depend
inclus
rsv
model
thu
effect
influenza
domin
rsv
uncov
account
variabl
rsv
model
model
covari
explain
devianc
frequenc
present
respiratori
syndrom
also
examin
differ
combin
viral
test
singl
predictor
combin
test
result
rsv
influenza
produc
bestfit
effect
adjust
rr
ci
figur
demonstr
correl
respiratori
syndrom
frequenc
rsv
influenza
effect
rsv
influenza
viru
respiratori
ill
shown
graphic
respiratori
viru
season
figur
previou
figur
test
result
shown
routin
collect
specimen
among
ed
patient
earlier
peak
respiratori
present
observ
decemb
correspond
peak
influenza
viru
activ
second
peak
februari
repres
rsv
activ
potenti
limit
studi
first
test
perform
identifi
sever
respiratori
virus
may
contribut
observ
burden
respiratori
ill
includ
rhinoviru
coronaviru
human
metapneumoviru
although
ad
virus
studi
might
chang
attribut
variabl
find
influenc
rsv
influenza
viru
quit
robust
unlik
effect
would
negat
inclus
addit
virus
model
anoth
potenti
concern
bias
test
order
might
make
routin
viral
test
result
unrepres
patient
present
ed
respiratori
syndrom
howev
result
prospect
test
among
ed
patient
respiratori
problem
close
correl
result
obtain
among
studi
popul
strongli
suggest
patient
test
fact
repres
patient
present
respiratori
syndrom
final
analyt
method
may
limit
presenc
yearli
season
overal
respiratori
ill
viral
preval
although
attempt
control
season
trend
includ
month
categor
variabl
difficult
know
whether
correct
adjust
made
effect
variabl
time
rate
posit
laboratori
test
common
respiratori
virus
larg
predict
fluctuat
patient
present
respiratori
problem
suggest
season
trend
respiratori
ill
observ
syndrom
surveil
system
direct
result
respiratori
viru
activ
rsv
influenza
viru
appear
greatest
impact
trend
respiratori
ill
observ
clinic
set
best
demonstr
recent
respiratori
viru
season
influenza
activ
began
unusu
earli
octob
peak
late
novemb
decemb
rapidli
declin
januari
februari
rsv
follow
typic
cours
increas
diseas
activ
begin
octob
peak
februari
gradual
declin
laboratori
test
institut
show
peak
influenza
rsv
activ
decemb
februari
respect
present
complaintbas
respiratori
syndrom
surveil
demonstr
bifid
peak
correspond
viral
activ
mani
current
syndrom
surveil
system
reli
data
collect
part
routin
clinic
workflow
exampl
data
includ
symptom
record
telephon
triag
center
nurs
advic
line
patient
complaint
obtain
present
ed
diagnosi
assign
physician
end
ambulatori
emerg
encount
advantag
use
data
readili
avail
time
fashion
collect
requir
addit
staff
resourc
mani
case
electron
form
sever
attempt
made
measur
accuraci
data
sourc
none
measur
relationship
laboratoryproven
viral
infect
popul
emerg
west
nile
viru
sar
avian
influenza
viru
among
infect
demonstr
need
effect
surveil
system
rapid
accur
diseas
detect
monitor
requir
reduc
potenti
morbid
associ
outbreak
studi
valid
correl
viral
ill
respiratori
syndrom
data
pediatr
ed
popul
present
complaint
patient
treat
physician
ed
officebas
practic
like
reflect
diseas
activ
winter
respiratori
virus
could
use
earli
indic
viral
activ
public
health
purpos
inform
may
also
benefit
physician
alert
unusu
pattern
ill
commonli
seen
commun
guid
diagnost
therapeut
decis
